Skip to main content
. 2022 Mar 1;13:817542. doi: 10.3389/fphys.2022.817542

FIGURE 3.

FIGURE 3

Empagliflozin inhibited gluconeogenesis and promoted glycogen synthesis in HL7702 cells. (A) Glucose production levels (n = 3 samples/group). (B) PEPCK and G6Pase activities (n = 3 samples/group). (C) Relative mRNA expression levels of PEPCK, G6PASE, FBP1, and PCX were measured by RT-PCR (n = 3 samples/group). (D) Relative protein expression levels of PEPCK and G6PASE were determined by western blotting (n = 3 samples/group). (E) Protein quantitative statistics (n = 3 samples/group). (F) PAS staining, scale bar = 100 μm (n = 6 samples/group). (G) Relative protein expression levels of p-AMPK, AMPK, p-GSK3β, GSK3β, p-CREB, and CREB were determined by western blotting. (H) Protein quantitative statistics (n = 3 samples/group). *P < 0.05, PA vs. PA+Empa; #P < 0.05, NC vs. PA. Arrows indicate the areas of focus for PAS staining.